Elective Non-cardiac Surgery

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
Leukocytes and Perioperative Cardio Vascular EventsN/A1 trial
Active Trials
NCT02874508Completed40Est. Dec 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Heidelberg PharmaLeukocytes and Perioperative Cardio Vascular Events

Clinical Trials (1)

Total enrollment: 40 patients across 1 trials

NCT02874508Heidelberg PharmaLeukocytes and Perioperative Cardio Vascular Events

Leukocytes and Perioperative Cardio Vascular Events

Start: Aug 2016Est. completion: Dec 201640 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space